Pages
Products
Human LILRB2 Stable Cell Line - HEK293T

Human LILRB2 Stable Cell Line - HEK293T

Cat.No. :  CSC-RO0664 Host Cell:  HEK293T

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-RO0664
Description This cell line is engineered to overexpress human leukocyte immunoglobulin like receptor B2 (LILRB2).
Gene LILRB2
Gene Species Homo sapiens (Human)
Host Cell HEK293T
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

1. Studying the interactions between immune cells and cancer cells

2. Studying the mechanisms of resistance to immune checkpoint blockade

3. High-throughput screening

4. Drug target validation

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Applications

Publications

Q & A

Customer Reviews

The Human LILRB2 Stable HEK293T Cell Line is a cellular model that is derived from the HEK293T cell line, which is a human embryonic kidney cell line. The LILRB2 gene in this cell line has been stably integrated and expressed, allowing researchers to study the function and signaling of the LILRB2 protein. LILRB2 is a member of the leukocyte immunoglobulin-like receptor family and is involved in immune response and inflammation. The stable HEK293T Cell Line is used to investigate the effects of LILRB2 inhibitors, which are potential novel therapies for diseases associated with excessive inflammation or immune response, such as autoimmune diseases and graft-versus-host disease. This cell line has been instrumental in the development of targeted treatments that could improve the outcomes for patients with these conditions. HEK293 cells were first established in 1978, and the HEK293T variant was derived from these cells in 1987. The “T” in HEK293T stands for “tumor,” indicating that these cells have been immortalized, or made cancerous, by the introduction of the SV40 large T antigen. This transformation allows the cells to grow indefinitely in culture, making them a valuable resource for researchers. HEK293T cells are known for their high protein expression and easy transfection with various vectors, making them an excellent choice for studying gene function, protein expression, and protein-protein interactions. The cells have a normal karyotype, meaning they have a normal number of chromosomes, and they are negative for the presence of mycoplasma, a bacteria that can contaminate cell lines.
The human LILRB2 stable HEK293 Cell Line, is an invaluable resource for researchers studying LILRB2 (lymphocyte immunoglobulin-like receptor B2) gene function and signalling pathways. This stable cell line can be used to study the role of LILRB2 in immune cell activation and signalling, providing insight into the mechanisms by which this receptor regulates inflammatory and immune responses. It can also be used to study the interaction between LILRB2 and its ligands, which is important for understanding the pathogenesis of diseases such as autoimmune diseases and cancer. In addition, the human LILRB2 stable HEK293 Cell Line, can be used to test the efficacy of new inhibitors or activators of LILRB2, which may have potential therapeutic use in the treatment of diseases associated with dysregulated immune responses.
Customer Q&As
What is the LILRB2 gene and its function?

A: The LILRB2 gene encodes for the leukocyte immunoglobulin-like receptor subfamily B member 2, also known as CD85j. This is a cell surface receptor expressed on myeloid cells, including monocytes and macrophages. LILRB2 plays a role in regulating immune responses by inhibiting the activation of T cells and natural killer cells.

How does the LILRB2 gene contribute to immune system regulation?

A: The LILRB2 gene contributes to immune system regulation by binding to MHC class I molecules on the surface of antigen-presenting cells. This interaction inhibits the activation of T cells, thus preventing inappropriate immune responses and maintaining tolerance to self-antigens.

Are there any diseases associated with mutations in the LILRB2 gene?

A: Mutations in the LILRB2 gene have been associated with various autoimmune diseases, where impaired function of the LILRB2 protein leads to an overactive immune response against the body's own tissues. Additionally, certain leukemias and lymphomas have been found to overexpress LILRB2, potentially influencing their pathogenesis.

How is the expression of the LILRB2 gene regulated?

A: The expression of the LILRB2 gene is regulated by various factors, including cytokines and transcription factors. For example, IL-6 and GM-CSF can upregulate LILRB2 expression in myeloid cells. The expression of LILRB2 is also influenced by epigenetic mechanisms, such as DNA methylation and histone modifications, which control its availability for transcription.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Timely Product Updates

The Human LILRB2 Stable Cell Line - HEK293T benefits from regular updates, ensuring that researchers have access to the latest advancements and improvements in cell line technology, enhancing the relevance and accuracy of their experiments.

Canada

06/30/2023

Advanced Editing Technology

Utilizing state-of-the-art editing technology, this cell line offers precise and efficient genetic modifications, allowing researchers to study LILRB2 with high accuracy and reliability, and opening up new possibilities for targeted research.

United Kingdom

05/06/2022

Multiple Editing Strategies

The Human LILRB2 Stable Cell Line - HEK293T employs a variety of editing strategies, providing researchers with flexibility and versatility in their experimental approaches, enabling them to explore different aspects of LILRB2 function and regulation.

French

11/10/2021

Minimal Off-target Risk

With an extremely low risk of off-target effects, the Human LILRB2 Stable Cell Line - HEK293T ensures that researchers can confidently conduct their experiments without the concern of unintended genetic alterations, leading to more reliable and meaningful results.

United States

03/16/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER